STOCK TITAN

Vicore Pharma: HBM may beneficially own about 8%

Vicore Pharma Holding AB’s Schedule 13G reports that HBM Healthcare Investments (Cayman) Ltd. may be deemed beneficial owner of 22,505,819 Common Shares, approximately 8% of the class, based on 281,644,509 Common Shares outstanding as of September 30, 2026.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Vicore Pharma Holding AB’s Schedule 13G reports that HBM Healthcare Investments (Cayman) Ltd. may be deemed beneficial owner of 22,505,819 Common Shares, approximately 8% of the class, based on 281,644,509 Common Shares outstanding as of September 30, 2026. HBM reports sole voting and dispositive power over 22,505,819 shares and no shared power. It reported 22,687,752 shares and approximately 8.1% as of June 30, 2026, based on 281,525,593 shares outstanding.

Voting and investment power over HBM’s shares is exercised by its board. The listed board members are Jean-Marc LeSieur, Managing Director, Richard H. Coles, Sophia Harris, Dr. Andreas Wicki, Mark Kronenfeld, M.D., and Richard Paul Woodhouse; none has individual voting or investment power.

Beneficial ownership 22,505,819 Common Shares HBM may have been deemed the beneficial owner as of the date of the statement
Ownership percentage Approximately 8% As of the date of the statement; based on 281,644,509 Common Shares outstanding as of September 30, 2026
Common Shares outstanding 281,644,509 Common Shares As of September 30, 2026
Beneficial ownership 22,687,752 Common Shares As of June 30, 2026
Ownership percentage Approximately 8.1% As of June 30, 2026; based on 281,525,593 Common Shares outstanding
ADS representation Ten Common Shares per ADS Each American Depositary Share represents ten Common Shares
beneficial owner financial
"may have been deemed the beneficial owner of 22,505,819 Common Shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
sole voting power financial
"Sole power to vote or to direct the vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"Sole power to dispose or to direct the disposition of"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
American Depositary Shares financial
"the issuer's American Depositary Shares ("ADSs")"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VCRE shares may HBM Healthcare Investments be deemed to own?

HBM may be deemed beneficial owner of 22,505,819 Common Shares, approximately 8% of the class. The percentage is based on 281,644,509 Common Shares outstanding as of September 30, 2026.

What does the CUSIP in VCRE’s ownership statement identify?

The CUSIP identifies Vicore Pharma Holding AB’s American Depositary Shares (ADSs), and each ADS represents ten Common Shares. The ADSs are not treated as a separate class for the stated beneficial-ownership calculation, which is reported in Common Shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates





92581R104

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Voting and investment power over the shares held by HBM Healthcare Investments (Cayman) Ltd. is exercised by the board of directors of HBM Healthcare Investments (Cayman) Ltd. (the "Board"). The Board consists of Jean-Marc LeSieur, Richard H. Coles, Sophia Harris, Dr. Andreas Wicki, Mark Kronenfeld, M.D., and Richard Paul Woodhouse, none of whom has individual voting or investment power with respect to the shares.


SCHEDULE 13G



HBM Healthcare Investments (Cayman) Ltd.
Signature:/s/ Jean-Marc LeSieur
Name/Title:Jean-Marc LeSieur, Managing Director
Date:10/13/2026

Keep reading